✨ Education and Health Notices




8 JUNE 2006 NEW ZEALAND GAZETTE, No. 53 1325

under authority delegated by the Secretary for Education,
I hereby cancel the licence dated 1 February 2006, which
was granted under those Regulations to Leah McConnon in
respect of Tokoroa Learning Centre 2 (30284), situated at
Balmoral Drive, Tokoroa.
This cancellation also has the effect of cancelling any
provisional licence issued to this service.

This notice shall take effect the day after the date of its
notification in the New Zealand Gazette.

JIM MATHESON, Acting Senior Manager, National
Operations.

go3699


Health

Medicines Act 1981

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set
out in the Schedule hereto:

Schedule

Product: Arcoxia
Active Ingredient: Etoricoxib 120mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck & Co Inc, Stonewall Plant, Elkton, Virginia, United States of America

Product: Arcoxia
Active Ingredient: Etoricoxib 60mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck & Co Inc, Stonewall Plant, Elkton, Virginia, United States of America

Product: Arcoxia
Active Ingredient: Etoricoxib 90mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck & Co Inc, Stonewall Plant, Elkton, Virginia, United States of America

Dated this 2nd day of June 2006.

KAREN MITCHELL, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health
on 6 July 2001).

go3806

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicines set out in the Schedule hereto:

Schedule

Product: AQuify Multi-Purpose Solution
Active Ingredient: Polihexanide 0.0001%w/v
Dosage Form: Contact lens solution
New Zealand Sponsor: Ciba Vision Australia Pty Limited
Manufacturer: Ciba Vision Canada Inc - Sterile Manufacturing, Mississauga, Ontario, Canada

Product: Blink Contacts Eye Drops
Active Ingredient: Sodium hyaluronate 1.5mg/mL
Dosage Form: Contact lens solution
New Zealand Sponsor: Advanced Medical Optics Australia Pty Limited
Manufacturer: AMO Manufacturing Spain SL, Ctra Fuencarral-Alcobendas, Alcobendas, Madrid, Spain



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2006, No 53


Gazette.govt.nz PDF NZ Gazette 2006, No 53





✨ LLM interpretation of page content

πŸŽ“ Cancellation of Licence for Tokoroa Learning Centre 2

πŸŽ“ Education, Culture & Science
Licence Cancellation, Early Childhood Education, Tokoroa Learning Centre 2
  • Leah McConnon, Licence cancelled for Tokoroa Learning Centre 2

  • Jim Matheson, Acting Senior Manager, National Operations

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
2 June 2006
Medicine Distribution, Medicines Act 1981, Arcoxia, Etoricoxib
  • Karen Mitchell, Acting Deputy Director-General, Public Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
2 June 2006
Medicine Distribution, Medicines Act 1981, AQuify Multi-Purpose Solution, Blink Contacts Eye Drops
  • Karen Mitchell, Acting Deputy Director-General, Public Health